Skip to main content

Evofem wins U.S. FDA approval for non-hormonal birth control gel

The U.S. Food and Drug Administration on Friday approved Evofem Biosciences Inc's birth control gel, ushering in the first non-hormonal contraceptive for women in over three decades.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.